82 FR 63 pgs. 16404-16405 - Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

Type: NOTICEVolume: 82Number: 63Pages: 16404 - 16405
FR document: [FR Doc. 2017-06536 Filed 4-3-17; 8:45 am]
Agency: Health and Human Services Department
Sub Agency: Centers for Disease Control and Prevention
Official PDF Version:  PDF Version
Pages: 16404, 16405

[top] page 16404

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): Initial Review

In accordance with Section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the Centers for Disease Control and Prevention (CDC) announces a meeting for the initial review of applications in response to Funding Opportunity Announcement (FOA) DP17-001, Community Characteristics Associated with Geographic Disparities in Diabetes and Cardiometabolic Health.

Times and Dates:

10:00 a.m.-6:00 p.m., EDT, April 25, 2017 (Closed)

10:00 a.m.-6:00 p.m., EDT, April 26, 2017 (Closed)

Place: Teleconference.

Status: The meeting will be closed to the public in accordance with provisions set forth in Section 552b(c) (4) and (6), Title 5 U.S.C., and the Determination of the Director, Management Analysis and Services Office, CDC, pursuant to Public Law 92-463.


[top] Matters for Discussion: The meeting will include the initial review, page 16405 discussion, and evaluation of applications received in response to "Community Characteristics Associated with Geographic Disparities in Diabetes and Cardiometabolic Health", DP17-001.

Contact Person for More Information: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488-6511, kva5@cdc.gov.

The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.

[FR Doc. 2017-06536 Filed 4-3-17; 8:45 am]

BILLING CODE 4163-18-P